Author:
von Mollendorf Claire,Licciardi Paul V
Reference8 articles.
1. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis;Shi;J Infect Dis,2020
2. The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy;Grant;Expert Rev Vaccines,2021
3. Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial;Platt;Lancet Infect Dis,2024
4. Long-term impact of pneumococcal conjugate vaccines from national, active, laboratory-based surveillance of invasive pneumococcal disease, South Africa, 2005–2019;Von Gottberg;SSRN,2023
5. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study;Ladhani;Lancet Infect Dis,2018